Loading...
XETR
GME
Market cap19mUSD
Dec 05, Last price  
3.10EUR
1D
-7.46%
1Q
-0.32%
Jan 2017
-73.64%
IPO
-69.73%
Name

Geratherm Medical AG

Chart & Performance

D1W1MN
XETR:GME chart
P/E
23.79
P/S
0.82
EPS
0.13
Div Yield, %
3.23%
Shrs. gr., 5y
1.80%
Rev. gr., 5y
0.57%
Revenues
20m
-8.41%
8,459,6728,589,6138,802,00310,734,56414,914,43617,783,09718,981,11116,280,27617,029,04018,714,64121,588,89522,062,98421,030,77921,521,92019,851,17627,466,23024,638,67325,850,61922,300,87320,425,225
Net income
705k
-36.54%
1,426,91900-2,920,6172,678,5452,542,2901,095,1151,194,1901,333,7811,682,3592,701,2652,236,805679,7871,153,595289,8572,045,328332,6471,023,4461,111,156705,172
CFO
2m
+30.47%
860,000240,9201,038,620473,0002,710,000427,0001,063,0001,605,0002,438,000952,0003,774,000792,0002,466,0001,347,0001,540,0003,915,000917,0002,606,0001,431,0001,867,000
Dividend
Aug 19, 20240.1 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; blood pressure monitors; and self-test diagnostic products for women, including pregnancy tests, chlamydia tests, urinary tract infections, diverse ovulation test solutions, and pH tests. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment offers MRI-compatible incubators for premature and newborn infants under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.
URL
https://www.geratherm.de
IPO date
Jul 03, 2000
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT